atopic dermatitis
FDA Grants New Indication for Dupixent for Young Children With Atopic Dermatitis
The new indication for children ranging from 6 months to 5 years of age makes Dupixent the first biologic approved ...
JUNE 8, 2022
Abrocitinib Approved to Treat Severe Atopic Dermatitis
The FDA approved a new oral medication for the treatment of moderate to severe atopic dermatitis in adults whose ...
JANUARY 19, 2022
Rinvoq Now Indicated to Treat Severe Atopic Dermatitis
The FDA granted a new indication for Rinvoq to treat severe atopic dermatitis in adults and children aged 12 years ...
JANUARY 18, 2022
Dupixent for Atopic Dermatitis Receives Pediatric Indication
Dupilumab is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 and IL-13 proteins, ...
MAY 29, 2020
Atopic Dermatitis in the Specialty World
Therapy for atopic dermatitis (AD), a chronic inflammatory skin disease that usually starts in infancy or early ...
AUGUST 12, 2019
FDA Approves Eucrisa for Atopic Dermatitis
Crisaborole, applied topically twice daily, is a phosphodiesterase-4 (PDE-4) inhibitor.
DECEMBER 15, 2016